Cargando…
Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies
BACKGROUND: Cardiovascular disease is a primary cause of death in patients with chronic obstructive pulmonary disease (COPD). Beta-blockers have been proved to reduce morbidity and improve survival in patients with cardiac diseases. But the effects of beta-blockers on outcomes in patients with COPD...
Autores principales: | Du, Qingxia, Sun, Yongchang, Ding, Ning, Lu, Lijin, Chen, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245088/ https://www.ncbi.nlm.nih.gov/pubmed/25427000 http://dx.doi.org/10.1371/journal.pone.0113048 |
Ejemplares similares
-
Beta-blocker use and COPD mortality: a systematic review and meta-analysis
por: Etminan, Mahyar, et al.
Publicado: (2012) -
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017) -
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017) -
Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017) -
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
por: Cotton, Seonaidh, et al.
Publicado: (2022)